These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32905515)

  • 1. Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.
    Sai S; Kim EH; Vares G; Suzuki M; Yu D; Horimoto Y; Hayashi M
    Am J Cancer Res; 2020; 10(8):2371-2386. PubMed ID: 32905515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.
    Sai S; Vares G; Kim EH; Karasawa K; Wang B; Nenoi M; Horimoto Y; Hayashi M
    Mol Cancer; 2015 Sep; 14():166. PubMed ID: 26338199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.
    Sai S; Wakai T; Vares G; Yamada S; Kamijo T; Kamada T; Shirai T
    Oncotarget; 2015 Mar; 6(8):5517-35. PubMed ID: 25849939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbon ion beam alone or in combination with cisplatin on malignant mesothelioma cells
    Sai S; Suzuki M; Kim EH; Hayashi M; Vares G; Yamamoto N; Miyamoto T
    Oncotarget; 2018 Mar; 9(19):14849-14861. PubMed ID: 29599911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior Effect of the Combination of Carbon-Ion Beam Irradiation and 5-Fluorouracil on Colorectal Cancer Stem Cells in vitro and in vivo.
    Koom WS; Sai S; Suzuki M; Fujimori A; Yamada S; Tsujii H
    Onco Targets Ther; 2020; 13():12625-12635. PubMed ID: 33335403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells.
    Oonishi K; Cui X; Hirakawa H; Fujimori A; Kamijo T; Yamada S; Yokosuka O; Kamada T
    Radiother Oncol; 2012 Nov; 105(2):258-65. PubMed ID: 23017870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-Ion Beam Irradiation and the miR-200c Mimic Effectively Eradicate Pancreatic Cancer Stem Cells Under in vitro and in vivo Conditions.
    Sai S; Kim EH; Koom WS; Vares G; Suzuki M; Yamada S; Hayashi M
    Onco Targets Ther; 2021; 14():4749-4760. PubMed ID: 34556996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays.
    Cui X; Oonishi K; Tsujii H; Yasuda T; Matsumoto Y; Furusawa Y; Akashi M; Kamada T; Okayasu R
    Cancer Res; 2011 May; 71(10):3676-87. PubMed ID: 21454414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib.
    Zhu X; Wu L; Qiao H; Han T; Chen S; Liu X; Jiang R; Wei Y; Feng D; Zhang Y; Ma Y; Zhang S; Zhang J
    J Cell Biochem; 2013 Dec; 114(12):2643-53. PubMed ID: 23794518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
    Yu T; Cho BJ; Choi EJ; Park JM; Kim DH; Kim IA
    Oncotarget; 2016 Nov; 7(48):79089-79100. PubMed ID: 27738326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
    Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
    BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.
    Siddique AB; Ebrahim HY; Akl MR; Ayoub NM; Goda AA; Mohyeldin MM; Nagumalli SK; Hananeh WM; Liu YY; Meyer SA; El Sayed KA
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).
    Baek SJ; Ishii H; Tamari K; Hayashi K; Nishida N; Konno M; Kawamoto K; Koseki J; Fukusumi T; Hasegawa S; Ogawa H; Hamabe A; Miyo M; Noguchi K; Seo Y; Doki Y; Mori M; Ogawa K
    Oncol Rep; 2015 Nov; 34(5):2233-7. PubMed ID: 26330103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion beam irradiation kills X-ray-resistant p53-null cancer cells by inducing mitotic catastrophe.
    Amornwichet N; Oike T; Shibata A; Ogiwara H; Tsuchiya N; Yamauchi M; Saitoh Y; Sekine R; Isono M; Yoshida Y; Ohno T; Kohno T; Nakano T
    PLoS One; 2014; 9(12):e115121. PubMed ID: 25531293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
    Gong L; Jin X; Li Q; Liu J; An L
    Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.
    Guo XF; Zhu XF; Zhong GS; Deng BG; Gao ZT; Wang H
    Oncol Rep; 2012 May; 27(5):1639-45. PubMed ID: 22293713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy ion irradiation increases apoptosis and STAT-3 expression, led to the cells arrested at G2/M phase in human hepatoma SMMC-7721 cells.
    Ma J; Ye L; Da M; Wang X
    Mol Cell Biochem; 2009 Aug; 328(1-2):17-23. PubMed ID: 19283452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
    Medina PJ; Goodin S
    Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines.
    Vannini I; Zoli W; Fabbri F; Ulivi P; Tesei A; Carloni S; Brigliadori G; Amadori D
    Anticancer Drugs; 2009 Nov; 20(10):918-25. PubMed ID: 19752719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.